Salcaprozate sodium

Modify Date: 2025-08-25 14:20:55

Salcaprozate sodium Structure
Salcaprozate sodium structure
Common Name Salcaprozate sodium
CAS Number 203787-91-1 Molecular Weight 301.313
Density N/A Boiling Point 521.7ºC at 760 mmHg
Molecular Formula C15H20NNaO4 Melting Point N/A
MSDS N/A Flash Point 269.3ºC

 Use of Salcaprozate sodium


Salcaprozate sodium (SNAC), an oral absorption promoter, and has the potential as a delivery agent for oral forms of heparin and insulin. Salcaprozate sodium could increase passive transcellular permeation across small intestinal epithelia based on increased lipophilicity arising from non-covalent macromolecule complexation[1][2].

 Names

Name Salcaprozate sodium
Synonym More Synonyms

 Salcaprozate sodium Biological Activity

Description Salcaprozate sodium (SNAC), an oral absorption promoter, and has the potential as a delivery agent for oral forms of heparin and insulin. Salcaprozate sodium could increase passive transcellular permeation across small intestinal epithelia based on increased lipophilicity arising from non-covalent macromolecule complexation[1][2].
Related Catalog
In Vitro SNAC (12.5-400 μg/mL; 24 h) has no toxicity to Caco-2 cells, and the survival percentage is above 90% when SNAC is 200 μg/mL[3]. SNAC (50 and 200 μg/mL) improves the apparent permeability coeffcient (Papp) of RA and SA-B by 2.14-fold and 3.68-fold compared with the Papp of SAs solution[3].
In Vivo SNAC improves the oral absorption of both R1 and SAs and enhances bioavailability in rats[3]. SNAC (2000 mg/kg/d; oral gavage for 13 weeks) related mortality is evident only at the 2000-mg/kg/d level, 20% among males and 50% among females; no clear cause of death is evident[1]. SNAC (100-1000 mg/kg/d; oral gavage for 13 weeks) induces no mortality in the Wistar rat study at doses up to 1000 mg/kg/d[1]. Animal Model: Sprague-Dawley rats (6-7 weeks)[1] Dosage: 2000 mg/kg/d Administration: Oral gavage for 13 weeks Result: Induced 20% and 50% mortality in males and females at the dose of 2000 mg/kg/d.
References

[1]. Riley MGI, et, al. Subchronic oral toxicity of salcaprozate sodium (SNAC) in Sprague-Dawley and Wistar rats. Int J Toxicol. Jul-Aug 2009; 28(4):278-93.

[2]. Twarog C, et, al. Intestinal Permeation Enhancers for Oral Delivery of Macromolecules: A Comparison between Salcaprozate Sodium (SNAC) and Sodium Caprate (C 10). Pharmaceutics. 2019 Feb 13; 11(2):78.

[3]. Li Y, et, al. Impact of Sodium N-[8-(2-Hydroxybenzoyl)amino]-caprylate on Intestinal Permeability for Notoginsenoside R1 and Salvianolic Acids in Caco-2 Cells Transport and Rat Pharmacokinetics. Molecules. 2018 Nov 16; 23(11):2990.

 Chemical & Physical Properties

Boiling Point 521.7ºC at 760 mmHg
Molecular Formula C15H20NNaO4
Molecular Weight 301.313
Flash Point 269.3ºC
Exact Mass 301.128998
PSA 89.46000
LogP 1.60340
Vapour Pressure 1.03E-11mmHg at 25°C

 Synonyms

Sodium 8-[(2-hydroxybenzoyl)amino]octanoate
E414
Octanoic acid, 8-[(2-hydroxybenzoyl)amino]-, sodium salt (1:1)
Salcaprozate sodium
SNAC
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here






Get all suppliers and price by the below link:

Salcaprozate sodium suppliers


Price: ¥800/25 mg

Reference only. check more Salcaprozate sodium price